Sudarshan Kriya Yoga for Ileocolitis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Yale New Haven Hospital, New Haven, CT
Ileocolitis+2 More
Sudarshan Kriya Yoga - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of CBT versus SKY on anxiety and depression in people with IBD. Sudarshan Kriya Yoga is being used to treat Ileocolitis in this trial and has been approved by the FDA for a different condition in the past. No patients will be given a placebo in this trial.

Eligible Conditions

  • Ileocolitis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: baseline, week 6, week 12, week 24 and week 52

Week 52
Change from baseline in anxiety scores using the Generalized Anxiety Disorder-7 (GAD-7) questionnaire
Week 52
Change from baseline in depression scores using the Patient Health Questionnaire-9 (PHQ-9)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Cognitive Behavioral Therapy
1 of 2
Sudarshan Kriya Yoga
1 of 2
Active Control
Experimental Treatment

152 Total Participants · 2 Treatment Groups

Primary Treatment: Sudarshan Kriya Yoga · No Placebo Group · N/A

Sudarshan Kriya Yoga
Behavioral
Experimental Group · 1 Intervention: Sudarshan Kriya Yoga · Intervention Types: Behavioral
Cognitive Behavioral Therapy
Behavioral
ActiveComparator Group · 1 Intervention: Cognitive Behavioral Therapy · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sudarshan Kriya Yoga
2019
Completed Phase 2
~330

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, week 6, week 12, week 24 and week 52
Closest Location: Yale New Haven Hospital · New Haven, CT
Photo of New Haven 1Photo of New Haven 2Photo of New Haven 3
2006First Recorded Clinical Trial
0 TrialsResearching Ileocolitis
157 CompletedClinical Trials

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,654 Previous Clinical Trials
20,829,489 Total Patients Enrolled
Crohn's & Colitis Foundation of America (CCFA)UNKNOWN
Jill Gaidos, MD, FACGPrincipal InvestigatorYale University

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have anxiety or depression and are aged 18 or older.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.